These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Pulsatile secretion of luteinizing hormone and prolactin in lactating and nonlactating women and the response to naltrexone. Kremer JA; Borm G; Schellekens LA; Thomas CM; Rolland R J Clin Endocrinol Metab; 1991 Feb; 72(2):294-300. PubMed ID: 1899421 [TBL] [Abstract][Full Text] [Related]
7. d-Lys-GHRP-6 does not modify the endocrine response to acylated ghrelin or hexarelin in humans. Benso A; Prodam F; Lucatello B; Gramaglia E; Riganti F; Schneider H; van der Lely AJ; Muccioli G; Ghigo E; Broglio F Neuropeptides; 2007 Feb; 41(1):45-9. PubMed ID: 17112585 [TBL] [Abstract][Full Text] [Related]
9. Is the mammosomatotrope a transitional cell for the functional interconversion of growth hormone- and prolactin-secreting cells? Suggestive evidence from virgin, gestating, and lactating rats. Porter TE; Hill JB; Wiles CD; Frawley LS Endocrinology; 1990 Dec; 127(6):2789-94. PubMed ID: 2123441 [TBL] [Abstract][Full Text] [Related]
10. Hyperprolactinemia after neonatal prolactin (PRL) deficiency in rats: evidence for altered anterior pituitary regulation of PRL secretion. Shah GV; Shyr SW; Grosvenor CE; Crowley WR Endocrinology; 1988 May; 122(5):1883-9. PubMed ID: 3129278 [TBL] [Abstract][Full Text] [Related]
11. Hyperprolactinemia caused by lactation and pituitary adenomas is associated with altered serum calcium, phosphate, parathyroid hormone (PTH), and PTH-related peptide levels. Kovacs CS; Chik CL J Clin Endocrinol Metab; 1995 Oct; 80(10):3036-42. PubMed ID: 7559893 [TBL] [Abstract][Full Text] [Related]
12. Twenty-four-hour growth hormone (GH)-releasing peptide (GHRP) infusion enhances pulsatile GH secretion and specifically attenuates the response to a subsequent GHRP bolus. Huhn WC; Hartman ML; Pezzoli SS; Thorner MO J Clin Endocrinol Metab; 1993 May; 76(5):1202-8. PubMed ID: 8496311 [TBL] [Abstract][Full Text] [Related]
13. Oral administration of growth hormone (GH)-releasing peptide stimulates GH secretion in normal men. Hartman ML; Farello G; Pezzoli SS; Thorner MO J Clin Endocrinol Metab; 1992 Jun; 74(6):1378-84. PubMed ID: 1592884 [TBL] [Abstract][Full Text] [Related]
14. Effects of sex and pregnancy hormones on growth hormone and prolactin receptor gene expression in insulin-producing cells. Møldrup A; Petersen ED; Nielsen JH Endocrinology; 1993 Sep; 133(3):1165-72. PubMed ID: 8365359 [TBL] [Abstract][Full Text] [Related]
15. Properties of growth hormone and prolactin hypersecretion by the human infant on the day of birth. de Zegher F; Devlieger H; Veldhuis JD J Clin Endocrinol Metab; 1993 May; 76(5):1177-81. PubMed ID: 8496309 [TBL] [Abstract][Full Text] [Related]
16. Abuse of recombinant human growth hormone: studies in two different dog models. Rigamonti AE; Scanniffio D; Bonomo SM; Cella SG; Sartorio A; Müller EE Neuroendocrinology; 2004; 79(5):237-46. PubMed ID: 15218318 [TBL] [Abstract][Full Text] [Related]
17. Failure of maintained hyperprolactinemia to improve lactational performance in late puerperium. Barguño JM; del Pozo E; Cruz M; Figueras J J Clin Endocrinol Metab; 1988 Apr; 66(4):876-9. PubMed ID: 3346364 [TBL] [Abstract][Full Text] [Related]